SCHEMBL15988604

SCHEMBL15988604

[CH2]C1(C)CCCN(CC2COc3ccccc3O2)C1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 3/20 0.64
ADRA2B P18089 3/20 0.64
ADRA2C P18825 3/20 0.64
ADRA1D P25100 3/20 0.64
ADRA1A P35348 3/20 0.64
ADRA1B P35368 3/20 0.64
SCN1A P35498 1/20 0.64
SCN2A Q99250 1/20 0.64
SCN3A Q9NY46 1/20 0.64
DRD2 P14416 8/20 0.62
HTR1A P08908 3/20 0.52
SIGMAR1 Q99720 2/20 0.52
MEN1 O00255 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15988308 1.00 ADRA2A (0.64) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL567617 0.83 ADRA2A (0.61) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL567316 0.83 DRD2 (0.63) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL566715 0.83 DRD2 (0.63) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL567706 0.82 DRD2 (0.62) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL3044736 0.81 DRD2 (0.64) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL567283 0.81 ADRA2A (0.58) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL3044732 0.81 DRD2 (0.64) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL30495456 0.81 ADRA2A (0.58) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL567626 0.81 ADRA2A (0.58) ADRA2AADRA2BADRA2CADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2176252-B1 2, 3-DIHYDROBENZO[1, 4]DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEME DISEASES ORION CORP (FI) 2014-09-03 EP claimed